Image by SDI Productions on Canva Pro
The compounding pharmacy market in Argentina is an evolving sector, experiencing growth in response to increased demand for personalized medication, particularly in therapeutic areas like derma, pain/ oncology management, nutritional supplements, and (HRT) hormone replacement therapy. Argentina’s compounding pharmacy market is expected to reach approximately USD 372.1 million by 2030, with a CAGR of 11-16%. This growth reflects the country’s focus on patient-centered healthcare, with a strong market presence in customized medications designed for specific health conditions.
Key Therapeutic Segments and Market Drivers
Figure 1. Compounding Pharmacy Market Overview in Argentina
There are several actively growing therapeutic segments in the Argentinian compounding pharmacy (also known as Pharmacy Magistral) market, including:
- HRT, which is increasingly popular in line with global trends;
- Dermatology, which caters to the demand for personalized skincare treatments;
- Nutritional supplements, which are the fastest-growing segment, driven by a shift towards wellness and preventive health;
- Pain management/ Oncology, which remains the leading revenue segment, as chronic pain conditions are prevalent in Argentina.
In terms of products, compounding pharmacies in Argentina prepare a wide range of formulations, including creams, ointments, tablets, and injectables, customized to address specific therapeutic needs.
Argentina’s Regulatory Landscape regarding compounding sector
The National Administration of Drugs, Foods, and Medical Devices (ANMAT) regulates compounding pharmacies (Pharmacy Magistral) in Argentina. Pharmacies must adhere to strict standards of quality, safety, and efficacy, as set by the Argentine Pharmacopoeia.
Licensed pharmacists are required to have specialized training, and facilities must use specialized equipment such as capsule-filling machines and electronic balances to meet these standards. Additionally, ANMAT’s regulations favor domestic production of high-cost compounded drugs, although importation is allowed for certain medications that are already registered internationally, streamlining access to essential treatments.
Despite the strict regulations, compounding pharmacies in Argentina are supported by several associations like – Confederación Farmacéutica Argentina (COFA) and Asociación Argentina de Farmacéuticos de Hospital (AAFH).
Figure 2. Leading Compounding Pharmacies in Argentina
Market Entry Potential and Market Challenges in Argentina’s compounding market
Despite the challenges due to economic instability and inflation, which affect pricing and supply chain continuity, the Argentinian compounding sector remains attractive for market entry, particularly for businesses ready to navigate these complexities and benefit from the demand for personalized health solutions.
This evolving market landscape, guided by regulatory bodies and supported by professional associations, positions Argentina’s compounding pharmacy sector as a promising environment for growth and innovation in personalized medicine.
At Chameleon Pharma Consulting Group (CPC), we are dedicated to facilitating your market entry, expansion, and regulatory/ registration across promising regions like Latin America, Europe, Asia, the US/Canada, the Middle East, and CEE/CIS. Our comprehensive services – including product & market analysis, international partner search, acquisitions, licensing, product registration, regulatory and GMP guidance – are designed to streamline your path to success. Embrace the opportunities ahead with CPC as your trusted partner, and together we can accelerate your global growth journey.
For your individual questions please contact us by e-mail at service@chameleon-pharma.com.
